文献速递炎症性肠病

循环microRNA-146b-5p作为监测炎症性肠病的新型生物标志物优于C反应蛋白

Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease.
PubMed 文献 · Aliment Pharmacol Ther · 2019-02-07

本研究通过发现队列(n=120)筛选17种候选血清microRNA,在独立训练队列(n=341)中验证,发现血清miR-146b-5p在克罗恩病和溃疡性结肠炎患者中分别较健康对照高2.87倍和2.72倍,且与疾病活动度相关,特异性优于C反应蛋白(CRP)。构建的克罗恩病分类器在验证队列(n=66)中识别内镜下活动的AUC为0.869,优于CRP的0.680。

要点

  • 血清miR-146b-5p在克罗恩病和溃疡性结肠炎中分别较健康对照高2.87倍和2.72倍。
  • 克罗恩病分类器识别内镜下活动的AUC为0.869,优于CRP的0.680。
  • miR-146b-5p可能比CRP更好地反映炎症性肠病黏膜炎症。

核心结论

  • miR-146b-5p可能比CRP更好地反映炎症性肠病黏膜炎症。
  • 本研究开发的克罗恩病分类器可能有助于识别克罗恩病患者的内镜下活动。

研究设计与样本

  • 发现队列(n=120)用定量实时聚合酶链反应测定17种候选microRNA的血清水平。
  • 差异表达的血清microRNA在独立训练队列(n=341)中进一步研究,并纳入疾病对照组探讨特异性。
  • 采用逻辑回归构建microRNA分类器以识别内镜下活动,并在验证队列(n=66)中用受试者工作特征曲线下面积(AUC)评估预测价值。

主要发现

  • 血清miR-146b-5p在克罗恩病患者中较健康对照高2.87倍,在溃疡性结肠炎患者中较健康对照高2.72倍。
  • 血清miR-146b-5p与疾病活动度显著相关,且特异性优于C反应蛋白(CRP)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Owing to the importance of early treatment, simple and reliable methods for monitoring inflammatory bowel disease (IBD) are needed. AIMS: To determine whether circulating microRNAs are reliable biomarkers for IBD monitoring. METHODS: Serum levels of 17 candidate microRNAs were measured by quantitative real-time polymerase chain reaction in a discovery cohort (n = 120). Differentially expressed serum microRNAs were further investigated in an independent training cohort (n = 341). Correlations between relative microRNA levels and disease activity were evaluated. A disease control group was included to investigate the specificity of microRNA. Logistical regression was used to construct a microRNA classifier to identify endoscopic activity. Its predictive value was explored in the validation cohort (n = 66) using the area under the receiver operating characteristic curve (AUC). RESULTS: Serum microRNA146b-5p (miR-146b-5p) expression was 2.87- and 2.72-fold higher in patients with Crohn's disease and ulcerative colitis, respectively, than in healthy controls. Serum miR-146b-5p was significantly correlated with disease activity and was more specific than C-reactive protein (CRP). A classifier was built for Crohn's disease, ie P [Endoscopically active] = 11+e2.937-0.737(miR-146b-5p)-0.008PLT , with a greater AUC of 0.869 [0.764-0.940] than that for CRP (0.680 [0.554-0.790]) (P = 0.0043). CONCLUSIONS: MiR-146b-5p may better reflect mucosal inflammation in IBD than CRP. The Crohn's disease classifier developed in this study may be valuable for identifying endoscopic activity in patients with Crohn's disease.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Chen P, Li Y, Li L, et al. Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease. Aliment Pharmacol Ther. 2019. PMID: 30734320. doi:10.1111/apt.15159

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。